-
1
-
-
33745234828
-
Resistance in gram-negative bacteria: Enterobacteriaceae
-
Paterson DL. 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34:S20-S28. http://dx.doi.org/10.1016/j.ajic.2006.05.238.
-
(2006)
Am J Infect Control
, vol.34
, pp. S20-S28
-
-
Paterson, D.L.1
-
2
-
-
12944295224
-
Bloodstream infections caused by antibiotic-resistant gramnegative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
-
Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant gramnegative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760-766. http://dx.doi.org/10.1128/AAC.49.2.760-766.2005.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 760-766
-
-
Kang, C.I.1
Kim, S.H.2
Park, W.B.3
Lee, K.D.4
Kim, H.B.5
Kim, E.C.6
Oh, M.D.7
Choe, K.W.8
-
3
-
-
39049128343
-
Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: An emerging public health concern
-
Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dis 8:159-166. http://dx.doi.org/10.1016/S1473-3099 (08) 70041-0.
-
(2008)
Lancet Infect Dis
, vol.8
, pp. 159-166
-
-
Pitout, J.D.1
Laupland, K.B.2
-
4
-
-
84867046103
-
Colistin: An update on the antibiotic of the 21st century
-
Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM. 2012. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect 10:917-934. http://dx.doi.org/10.1586/eri.12.78.
-
(2012)
Expert Rev Anti Infect
, vol.10
, pp. 917-934
-
-
Biswas, S.1
Brunel, J.M.2
Dubus, J.C.3
Reynaud-Gaubert, M.4
Rolain, J.M.5
-
5
-
-
79952789048
-
Does broadspectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
-
Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broadspectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689-692. http://dx.doi.org/10.1093/jac/dkq520.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 689-692
-
-
Nordmann, P.1
Poirel, L.2
Toleman, M.A.3
Walsh, T.R.4
-
7
-
-
79953710021
-
Novel classes of antibiotics or more of the same?
-
Coates AR, Halls G, Hu Y. 2011. Novel classes of antibiotics or more of the same? Br J Pharmacol 163:184-194. http://dx.doi.org/10.1111/j.1476-5381.2011.01250.x.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 184-194
-
-
Coates, A.R.1
Halls, G.2
Hu, Y.3
-
8
-
-
4644242447
-
Antibacterial research and development in the 21st Century: An industry perspective of the challenges
-
Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H. 2004. Antibacterial research and development in the 21st Century: an industry perspective of the challenges. Curr Opin Microbiol 7:445-450. http://dx.doi.org/10.1016/j.mib.2004.08.009.
-
(2004)
Curr Opin Microbiol
, vol.7
, pp. 445-450
-
-
Thomson, C.J.1
Power, E.2
Ruebsamen-Waigmann, H.3
Labischinski, H.4
-
10
-
-
79956079536
-
Antibiotic adjuvants: Multicomponent antiinfective strategies
-
Kalan L, Wright GD. 2011. Antibiotic adjuvants: multicomponent antiinfective strategies. Expert Rev Mol Med 13:e5. http://dx.doi.org/10.1017/S1462399410001766.
-
(2011)
Expert Rev Mol Med
, vol.13
, pp. e5
-
-
Kalan, L.1
Wright, G.D.2
-
11
-
-
84923280146
-
Combinations of beta-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus
-
Hu Y, Liu A, Vaudrey J, Vaiciunaite B, Moigboi C, McTavish SM, Kearns A, Coates A. 2015. Combinations of beta-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus. PLoS One 10:e0117664. http://dx.doi.org/10.1371/journal.pone.0117664.
-
(2015)
PLoS One
, vol.10
, pp. e0117664
-
-
Hu, Y.1
Liu, A.2
Vaudrey, J.3
Vaiciunaite, B.4
Moigboi, C.5
McTavish, S.M.6
Kearns, A.7
Coates, A.8
-
12
-
-
84994034233
-
Can we prevent antimicrobial resistance by using antimicrobials better?
-
Soothill G, Hu Y, Coates A. 2013. Can we prevent antimicrobial resistance by using antimicrobials better? Pathogens 2:422-435. http://dx.doi.org/10.3390/pathogens2020422.
-
(2013)
Pathogens
, vol.2
, pp. 422-435
-
-
Soothill, G.1
Hu, Y.2
Coates, A.3
-
13
-
-
77951093826
-
Impact of the antimicrobial peptide novicidin on membrane structure and integrity
-
Nielsen SB, Otzen DE. 2010. Impact of the antimicrobial peptide novicidin on membrane structure and integrity. J Colloid Interface Sci 345:248-256. http://dx.doi.org/10.1016/j.jcis.2010.01.065.
-
(2010)
J Colloid Interface Sci
, vol.345
, pp. 248-256
-
-
Nielsen, S.B.1
Otzen, D.E.2
-
14
-
-
77956072900
-
Membrane interactions of novicidin, a novel antimicrobial peptide: Phosphatidylglycerol promotes bilayer insertion
-
Dorosz J, Gofman Y, Kolusheva S, Otzen D, Ben-Tal N, Nielsen NC, Jelinek R. 2010. Membrane interactions of novicidin, a novel antimicrobial peptide: phosphatidylglycerol promotes bilayer insertion. J Phys Chem B 114:11053-11060. http://dx.doi.org/10.1021/jp1052248.
-
(2010)
J Phys Chem B
, vol.114
, pp. 11053-11060
-
-
Dorosz, J.1
Gofman, Y.2
Kolusheva, S.3
Otzen, D.4
Ben-Tal, N.5
Nielsen, N.C.6
Jelinek, R.7
-
15
-
-
84878112718
-
Novicidin's membrane permeabilizing activity is driven by membrane partitioning but not by helicity: A biophysical study of the impact of lipid charge and cholesterol
-
Balakrishnan VS, Vad BS, Otzen DE. 2013. Novicidin's membrane permeabilizing activity is driven by membrane partitioning but not by helicity: a biophysical study of the impact of lipid charge and cholesterol. Biochim Biophys Acta 1834:996-1002. http://dx.doi.org/10.1016/j.bbapap. 2013.03.025.
-
(2013)
Biochim Biophys Acta
, vol.1834
, pp. 996-1002
-
-
Balakrishnan, V.S.1
Vad, B.S.2
Otzen, D.E.3
-
16
-
-
0038601510
-
Synergy, antagonism, and what the chequerboard puts between them
-
Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. http://dx.doi.org/10.1093/jac/dkg301.
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 1
-
-
Odds, F.C.1
-
17
-
-
0029800028
-
Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard, and E test
-
White RL, Burgess DS, Manduru M, Bosso JA. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40:1914-1918.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 1914-1918
-
-
White, R.L.1
Burgess, D.S.2
Manduru, M.3
Bosso, J.A.4
-
18
-
-
84872389940
-
Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin, and chlorhexidine: In vitro and in vivo studies
-
Hu Y, Coates AR. 2012. Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin, and chlorhexidine: in vitro and in vivo studies. J Antimicrob Chemother 68:374-384. http://dx.doi.org/10.1093/jac/dks384.
-
(2012)
J Antimicrob Chemother
, vol.68
, pp. 374-384
-
-
Hu, Y.1
Coates, A.R.2
-
19
-
-
0032957681
-
Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane
-
Wu M, Hancock RE. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 274:29-35. http://dx.doi.org/10.1074/jbc.274.1.29.
-
(1999)
J Biol Chem
, vol.274
, pp. 29-35
-
-
Wu, M.1
Hancock, R.E.2
-
20
-
-
0026709689
-
The postantibiotic effect
-
Spivey JM. 1992. The postantibiotic effect. Clin Pharm 11:865-875.
-
(1992)
Clin Pharm
, vol.11
, pp. 865-875
-
-
Spivey, J.M.1
-
21
-
-
84937141124
-
An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: New challenges for the present and the future
-
Rodriguez-Pardo D, Pigrau C, Corona PS, Almirante B. 2015. An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future. Expert Rev Anti-Infect Ther 13:249-265. http://dx.doi.org/10.1586/14787210.2015.999669.
-
(2015)
Expert Rev Anti-infect Ther
, vol.13
, pp. 249-265
-
-
Rodriguez-Pardo, D.1
Pigrau, C.2
Corona, P.S.3
Almirante, B.4
-
22
-
-
84903384235
-
Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gramnegative bacteria
-
Nastro M, Rodriguez CH, Monge R, Zintgraff J, Neira L, Rebollo M, Vay C, Famiglietti A. 2014. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gramnegative bacteria. J Chemother 26:211-216. http://dx.doi.org/10.1179/1973947813Y.0000000136.
-
(2014)
J Chemother
, vol.26
, pp. 211-216
-
-
Nastro, M.1
Rodriguez, C.H.2
Monge, R.3
Zintgraff, J.4
Neira, L.5
Rebollo, M.6
Vay, C.7
Famiglietti, A.8
-
23
-
-
70849121220
-
Rifampicin combined regimens for gram-negative infections: Data from the literature
-
Drapeau CM, Grilli E, Petrosillo N. 2010. Rifampicin combined regimens for gram-negative infections: data from the literature. Int J Antimicrob Agents 35:39-44. http://dx.doi.org/10.1016/j.ijantimicag.2009.08.011.
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 39-44
-
-
Drapeau, C.M.1
Grilli, E.2
Petrosillo, N.3
-
24
-
-
0019800951
-
Pharmacokinetics of ceftriaxone in humans
-
Patel IH, Chen S, Parsonnet M, Hackman MR, Brooks MA, Konikoff J, Kaplan SA. 1981. Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother 20:634-641. http://dx.doi.org/10.1128/AAC.20.5.634.
-
(1981)
Antimicrob Agents Chemother
, vol.20
, pp. 634-641
-
-
Patel, I.H.1
Chen, S.2
Parsonnet, M.3
Hackman, M.R.4
Brooks, M.A.5
Konikoff, J.6
Kaplan, S.A.7
-
25
-
-
0021051292
-
High-pressure liquid chromatographic analysis of ceftazidime in serum and urine
-
Leeder JS, Spino M, Tesoro AM, MacLeod SM. 1983. High-pressure liquid chromatographic analysis of ceftazidime in serum and urine. J Antimicrob Chemother 24:720-724. http://dx.doi.org/10.1128/AAC.24.5.720.
-
(1983)
J Antimicrob Chemother
, vol.24
, pp. 720-724
-
-
Leeder, J.S.1
Spino, M.2
Tesoro, A.M.3
MacLeod, S.M.4
-
26
-
-
13944278028
-
Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections
-
Burgess DS. 2005. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections. Clin Infect Dis 40(Suppl 2):S99-S104. http://dx.doi.org/10.1086/426189.
-
(2005)
Clin Infect Dis
, vol.40
, pp. S99-S104
-
-
Burgess, D.S.1
-
27
-
-
0034036205
-
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia
-
Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Fortuna M, Drenaggi D, Scalise G. 2000. In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44:1716-1719. http://dx.doi.org/10.1128/AAC.44.6.1716-1719.2000.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1716-1719
-
-
Giacometti, A.1
Cirioni, O.2
Del Prete, M.S.3
Barchiesi, F.4
Fortuna, M.5
Drenaggi, D.6
Scalise, G.7
-
28
-
-
77951251397
-
Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novodesigned antimicrobial peptides
-
Anantharaman A, Rizvi MS, Sahal D. 2010. Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novodesigned antimicrobial peptides. Antimicrob Agents Chemother 54:1693-1699. http://dx.doi.org/10.1128/AAC.01231-09.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1693-1699
-
-
Anantharaman, A.1
Rizvi, M.S.2
Sahal, D.3
-
29
-
-
84867638118
-
Mechanisms of peptide-induced pore formation in lipid bilayers investigated by oriented 31P solid-stateNMRspectroscopy
-
Bertelsen K, Dorosz J, Hansen SK, Nielsen NC, Vosegaard T. 2012. Mechanisms of peptide-induced pore formation in lipid bilayers investigated by oriented 31P solid-stateNMRspectroscopy. PLoS One 7:e47745. http://dx.doi.org/10.1371/journal.pone.0047745.
-
(2012)
PLoS One
, vol.7
, pp. e47745
-
-
Bertelsen, K.1
Dorosz, J.2
Hansen, S.K.3
Nielsen, N.C.4
Vosegaard, T.5
-
30
-
-
78649912244
-
Efflux pumps of gram-negative bacteria, a new target for new molecules
-
Pages JM, Sandrine AF, Mahamoud A, Bolla JM, Davin-Regli A, Chevalier J, Garnotel E. 2010. Efflux pumps of gram-negative bacteria, a new target for new molecules. Curr Top Med Chem 10:1848-1857. http://dx.doi.org/10.2174/156802610793176620.
-
(2010)
Curr Top Med Chem
, vol.10
, pp. 1848-1857
-
-
Pages, J.M.1
Sandrine, A.F.2
Mahamoud, A.3
Bolla, J.M.4
Davin-Regli, A.5
Chevalier, J.6
Garnotel, E.7
-
31
-
-
62749178622
-
Inhibitors of multidrug resistant efflux systems in bacteria
-
Zechini B, Versace I. 2009. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Anti infect Drug Discov 4:37-50. http://dx.doi.org/10.2174/157489009787260061.
-
(2009)
Recent Pat Anti Infect Drug Discov
, vol.4
, pp. 37-50
-
-
Zechini, B.1
Versace, I.2
-
32
-
-
0022462392
-
Specific location of penicillin-binding proteins within the cell envelope of Escherichia coli
-
Barbas JA, Diaz J, Rodriguez-Tebar A, Vazquez D. 1986. Specific location of penicillin-binding proteins within the cell envelope of Escherichia coli. J Bacteriol 165:269-275.
-
(1986)
J Bacteriol
, vol.165
, pp. 269-275
-
-
Barbas, J.A.1
Diaz, J.2
Rodriguez-Tebar, A.3
Vazquez, D.4
-
33
-
-
77951249813
-
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae
-
Kosowska-Shick K, McGhee PL, Appelbaum PC. 2010. Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 54:1670-1677. http://dx.doi.org/10.1128/AAC.00019-10.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1670-1677
-
-
Kosowska-Shick, K.1
McGhee, P.L.2
Appelbaum, P.C.3
|